Hera-MI
Entity

  • Hera-MI

    Created in 2017
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    10 11 2,237

  • Activities

    deeptech healthtech

  • Technologies

    A.I.

  • Entity types

    Startup

  • Location

    4 Rue Duguay Trouin, 44800 Saint-Herblain, France

    Saint-Herblain

    France

  • Employees

    Scale: 11-50

    Estimated: 18

  • SIREN

    828871699

  • Engaged corporates

    1
    1 0

  • Added in Motherbase

    1 year, 3 months ago
Description
  • Value proposition

    Shaping the future of radiology by making AI & Radiologists working together to improve breast cancer early detection

    Hera-MI brings AI to improve breast cancer early detection to increase recovery rate and to optimize healthcare treatment for women.

    Breast Cancer is one of the leading cancer causes among women. However, when diagnosed early, patient can recover in almost 90% of cases.

    Hera-MI is developing a clinical decision support system based on machine learning and medical imaging processing that improve breast cancer early detection. The system enhance diagnosis quality and accuracy while reducing radiologists interpretation time.

    Moreover Hera-MI solution focuses on patient care improvement. With the more efficient breast cancer screening it allows women to be treated earlier and thus offers them higher chances for recovery.


    Breast Cancer, Mammography, Tomosynthesis, MRI, 3D Ultrasound, Elastography, software, Artificial Intelligence, Image Processing, Medical Imaging, Clinical Decision Support System, Senology, IA, Mammographie, CAD, sénologie, cancer du sein, tomosynthèse, and AI

  • Original language

    L'IA au service du diagnostic radiologique du cancer du sein.

    Hera-MI axe ses recherches sur l’intelligence artificielle appliquée à l’imagerie médicale dans le cadre du diagnostic du cancer.

    Notre objectif est de répondre aux enjeux sanitaires de demain en améliorant l’expérience du système de santé par l’IA.

    Nous développons des solutions logicielles d’aide à la décision médicale au bénéfice des radiologues, des sénologues, des manipulateurs en électroradiologie et des patients.

    Nous avons conçu un premier dispositif médical appelé Breast-SlimView®, un logiciel breveté d’aide à la décision en mammographie 2D et 3D (tomosynthèse) pour le dépistage du cancer du sein. 🎗️

  • Hera-MI - Solution d'IA en mammographie et tomosynthèse

    Découvrez comment notre solution d'Intelligence artificielle Breast-SlimView® soutient les radiologues au quotidien !

    • https://www.hera-mi.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Atlanpole Biotherapies
Atlanpole Biotherapies
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
Atlanpole Biotherapies
Public business cluster, Biotechnology, French Cluster, Biotechnology Research 		Other

26 Oct 2022


Similar entities
Last news
Show all articles
Social network dynamics